HISAMITSU PHARMACEUTICAL CO.,INC. (4530)

Market cap
¥514.8B
P/E ratio
19.9x
Hisamitsu Pharmaceutical manufactures and sells over-the-counter medications like allergy treatments, operating globally through subsidiaries in the US, Europe, and Asia.
Period EndProperty, plant and equipment, net (Million JPY)YoY (%)
Feb 28, 202660,519+1.04%
Feb 28, 202559,899+21.10%
Feb 29, 202449,462+14.47%
Feb 28, 202343,209+10.60%
Feb 28, 202239,069+4.59%
Feb 28, 202137,354-3.22%
Feb 29, 202038,596-2.43%
Feb 28, 201939,556-1.27%
Feb 28, 201840,064-6.90%
Feb 28, 201743,031-1.87%
Feb 29, 201643,851-2.56%
Feb 28, 201545,003
AI Chat